Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CADL compared with URGN: revenue, margins and what each company keeps, and the suppliers and customers both name
CADL
Candel Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
URGN
UroGen Pharma Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CADL
Candel Therapeutics, Inc.
vs
URGN
UroGen Pharma Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CADL, solid
URGN, dashed
CADL
Candel Therapeutics, Inc.
Change
8.74
▲
+8.71%
· post 8.68
Mkt cap
$669.5M
Revenue
—
Revenue
—
URGN
UroGen Pharma Ltd.
Change
24.77
▼
−3.72%
· post 24.38
Closed
Nov 6 '26
Mkt cap
$1.2B
Revenue
$89M
Q3 FY26
Revenue
$110M
FY25
vs
Compare
Closed
Nov 6 '26
CADL
Candel Therapeutics, Inc.
vs
URGN
UroGen Pharma Ltd.
8.74
▲
+8.71%
post 8.68
Price
24.77
▼
−3.72%
post 24.38
$669.5M
Mkt cap
$1.2B
—
Revenue
$89M
Q3 FY26
—
Revenue
$110M
FY25
Change
Change
CADL
8.74
▲
+8.71%
vs
URGN
24.77
▼
−3.72%
Closed
Nov 6 '26